ID   CH03
AC   CVCL_V562
SY   BCSCH03
DR   Cosmic; 2076359
DR   Wikidata; Q54811603
RX   PubMed=23958880;
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr107Thrfs*15 (c.318delC); Zygosity=Unspecified (PubMed=23958880).
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
ST   Source(s): PubMed=23958880
ST   Amelogenin: X
ST   D16S539: 9,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 24
ST   D3S1358: 15,17
ST   D8S1179: 11,14
ST   FGA: 23
ST   TH01: 8,9
ST   vWA: 17
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
RX   PubMed=23958880; DOI=10.1038/labinvest.2013.101;
RA   Monderer D., Luseau A., Bellec A., David E., Ponsolle S., Saiagh S.,
RA   Bercegeay S., Piloquet P., Denis M.G., Lode L., Redini F., Biger M.,
RA   Heymann D., Heymann M.-F., Le Bot R., Gouin F., Blanchard F.;
RT   "New chondrosarcoma cell lines and mouse models to study the link
RT   between chondrogenesis and chemoresistance.";
RL   Lab. Invest. 93:1100-1114(2013).
//